DFC
DB Fitzpatrick & Co’s Edwards Lifesciences EW Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.45M | Buy |
18,519
+67
| +0.4% | +$5.24K | 1.29% | 20 |
|
|
2025
Q1 | $1.34M | Sell |
18,452
-2,082
| -10% | -$151K | 1.27% | 18 |
|
|
2024
Q4 | $1.52M | Sell |
20,534
-472
| -2% | -$34.9K | 1.4% | 18 |
|
|
2024
Q3 | $1.39M | Buy |
21,006
+66
| +0.3% | +$4.36K | 1.22% | 31 |
|
|
2024
Q2 | $1.93M | Sell |
20,940
-154
| -0.7% | -$14.2K | 1.79% | 9 |
|
|
2024
Q1 | $2.02M | Buy |
21,094
+57
| +0.3% | +$5.45K | 1.85% | 6 |
|
|
2023
Q4 | $1.6M | Buy |
21,037
+3,213
| +18% | +$245K | 1.54% | 15 |
|
|
2023
Q3 | $1.23M | Buy |
17,824
+67
| +0.4% | +$4.64K | 1.32% | 22 |
|
|
2023
Q2 | $1.68M | Sell |
17,757
-911
| -5% | -$85.9K | 1.77% | 8 |
|
|
2023
Q1 | $1.54M | Buy |
18,668
+1,062
| +6% | +$87.9K | 1.67% | 14 |
|
|
2022
Q4 | $1.31M | Buy |
17,606
+5,196
| +42% | +$388K | 1.5% | 18 |
|
|
2022
Q3 | $1.03M | Sell |
12,410
-1,407
| -10% | -$116K | 1.25% | 29 |
|
|
2022
Q2 | $1.31M | Buy |
13,817
+527
| +4% | +$50.1K | 1.45% | 21 |
|
|
2022
Q1 | $1.56M | Buy |
13,290
+300
| +2% | +$35.3K | 1.56% | 18 |
|
|
2021
Q4 | $1.68M | Buy |
+12,990
| New | +$1.68M | 1.57% | 14 |
|